Woman reading in MDC library

Veröffentlichungen

10 Ergebnisse:
Active Filter:
Sortieren:
in Blood

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

  • S. Reinke
  • P.J. Bröckelmann
  • I. Iaccarino
  • M. Garcia-Marquez
  • S. Borchmann
  • F. Jochims
  • M. Kotrova
  • K. Pal
  • M. Brüggemann
  • E. Hartmann
  • S. Sasse
  • C. Kobe
  • S. Mathas
  • M. Soekler
  • U. Keller
  • M. Bormann
  • A. Zimmermann
  • J. Richter
  • M. Fuchs
  • B. von Tresckow
  • P. Borchmann
  • H. Schlößer
  • M. von Bergwelt-Baildon
  • A. Rosenwald
  • A. Engert
  • W. Klapper
in JAMA Oncol

Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial

  • P.J. Bröckelmann
  • H. Goergen
  • U. Keller
  • J. Meissner
  • R. Ordemann
  • T.V. Halbsguth
  • S. Sasse
  • M. Sökler
  • A. Kerkhoff
  • S. Mathas
  • A. Hüttmann
  • M. Bormann
  • A. Zimmermann
  • J. Mettler
  • M. Fuchs
  • B. von Tresckow
  • C. Baues
  • A. Rosenwald
  • W. Klapper
  • C. Kobe
  • P. Borchmann
  • A. Engert
in Hum Gene Ther

CD8-specific designed ankyrin repeat proteins improve selective gene delivery into human and primate T lymphocytes

  • A.M. Frank
  • T. Weidner
  • J. Brynza
  • W. Uckert
  • C.J. Buchholz
  • J. Hartmann
in Eur J Immunol

ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope

  • K. Textoris-Taube
  • C. Cammann
  • P. Henklein
  • E. Topfstedt
  • F. Ebstein
  • S. Henze
  • J. Liepe
  • F. Zhao
  • D. Schadendorf
  • B. Dahlmann
  • W. Uckert
  • A. Paschen
  • M. Mishto
  • U. Seifert
in Eur J Immunol

Designer T cells by T cell receptor replacement

  • D. Sommermeyer
  • J. Neudorfer
  • M. Weinhold
  • M. Leisegang
  • B. Engels
  • E. Noessner
  • M.H. Heemskerk
  • J. Charo
  • D.J. Schendel
  • T. Blankenstein
  • H. Bernhard
  • W. Uckert
in Blood

Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma

  • J.I. Martin-Subero
  • I. Wlodarska
  • C. Bastard
  • J.M. Picquenot
  • J. Hoeppner
  • M. Giefing
  • W. Klapper
  • R. Siebert
  • S. Mathas
  • S. Joos
  • H. Stein
  • B. Doerken
in Cell Cycle

Reprogramming of B lymphoid cells in human lymphoma pathogenesis

  • M. Janz
  • B. Doerken
  • S. Mathas
in Blood

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

  • M. Janz
  • M. Hummel
  • M. Truss
  • B. Wollert-Wulf
  • S. Mathas
  • K. Joehrens
  • C. Hagemeier
  • K. Bommert
  • H. Stein
  • B. Doerken
  • R.C. Bargou
in Cell Mol Life Sci

The translocation motif of hepatitis B virus improves protein vaccination

  • E. Bleifuss
  • T. Kammertoens
  • A. Hutloff
  • D. Quarcoo
  • M. Dorner
  • P. Straub
  • W. Uckert
  • E. Hildt
in Nat Immunol

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

  • S. Mathas
  • M. Janz
  • F. Hummel
  • M. Hummel
  • B. Wollert-Wulf
  • S. Lusatis
  • I. Anagnostopoulos
  • A. Lietz
  • M. Sigvardsson
  • F. Jundt
  • K. Joehrens
  • K. Bommert
  • H. Stein
  • B. Doerken